Current Neuropharmacology
Title: Erratum
Volume: 5 Issue: 3
Export Options
About this article
Cite this article as:
Erratum, Current Neuropharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157015907781695892
DOI https://dx.doi.org/10.2174/157015907781695892 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
14
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety P2X4 Receptors of Microglia in Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Opioids and Cannabinoids Interactions: Involvement in Pain Management
Current Drug Targets Farewell Note
Recent Patents on CNS Drug Discovery (Discontinued) GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action
CNS & Neurological Disorders - Drug Targets Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer’s Disease
Current Neuropharmacology The Piccolo Intronic Single Nucleotide Polymorphism rs13438494 Regulates Dopamine and Serotonin Uptake and Shows Associations with Dependence-Like Behavior in Genomic Association Study
Current Molecular Medicine Recent Insights into the Involvement of Progranulin in Frontotemporal Dementia
Current Neuropharmacology Erlotinib in Glioblastoma - Lost in Translation?
Anti-Cancer Agents in Medicinal Chemistry Tianeptine: An Atypical Antidepressant with Multimodal Pharmacology
Current Psychopharmacology Development of Prolactin Receptor Antagonists: Same Goal, Different Ways
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Epigenetics and Periodontal Disease: Hope to Tame the Untameable
Current Gene Therapy Meet Our Editorial Board Member
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Development of Fluorinated Thienylchalcones as Monoamine Oxidase-B Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking Studies
Letters in Organic Chemistry Immunotherapy for Prostate Cancer
Current Pharmaceutical Design How Internet Technology Can Improve the Quality of Care for Substance Use Disorders
Current Drug Abuse Reviews Gender Differences in Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Hematologic Abnormalities in the Antiphospholipid Syndrome
Current Rheumatology Reviews Derivatives as 5HT1A Receptor Ligands-Past and Present
Current Medicinal Chemistry CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders
Current Drug Targets